Mt. Sinai Medical Center

New York, New York 27705

3 studies enrolling now · 69 studies all time

What they study most

AIDS, AL Amyloidosis, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adherence, Advanced Malignancies, Advanced Refractory Left Ventricular Heart Failure, Allergy, Peanut, Alzheimer Disease, Anxiety Disorder, Aortoiliac Occlusive Disease

Studies at this site

• An Extension Study for Patients Previously Enrolled in Studies With Pelabresib — Recruiting now
• The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease — Recruiting now
• Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder — Recruiting now
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma — Running, not enrolling
• Long-term Extension Study of Ligelizumab in Food Allergy — Stopped early
• Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) — Completed
• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling
• Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System — Completed
• Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy — Stopped early
• Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile — Completed
• MOMENTUM 3 IDE Clinical Study Protocol — Completed
• MOMENTUM 3 Continued Access Protocol — Completed
• Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management — Completed
• Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates — Stopped early
• Double Cord Versus Haploidentical (BMT CTN 1101) — Completed
• RAD001 for Patients With Radioiodine Refractory Thyroid Cancer — Completed
• Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C — Completed
• A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. — Withdrawn before enrolling
• CMX001 in Post-transplant Patients With BK Virus Viruria — Completed
• Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer — Completed
• A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients — Completed
• Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant — Completed
• A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice — Completed
• Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis — Completed
• Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3) — Stopped early
• The Second Multicenter Hemophilia Cohort Study — Completed
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality — Completed
• Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder — Completed
• Prenatal Microarray Follow-Up Study — Completed
• Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation — Completed
• Proof of Concept Study for 1 Lead Patch Technology — Stopped early
• Clinical Trial on Treatment of Intraventricular Hemorrhage — Completed
• Imuran Dosing in Crohn's Disease Study — Stopped early
• Neuropsychological Evaluation of Psychiatric and Neurological Patients — Completed
• Stem Cell Related Donor Safety Study — Completed
• IGIV Study for Chronic ITP Patients Ages 3-70 — Completed
• Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma — Completed
• Vital Signs Patch Early Feasibility and Usability Study — Completed
• Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma — Completed
• Effect IV Ibuprofen and Inflammatory Responses — Completed
• Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss — Status unconfirmed
• Parastomal Reinforcement With Strattice — Completed
• Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation — Completed
• Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease — Completed
• WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation — Completed
• Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease — Completed
• Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C — Completed
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases — Stopped early